Literature DB >> 32392631

Estimating the prevalence of problem drug use from drug-related mortality data.

Hayley E Jones1, Ross J Harris2, Beatrice C Downing1, Matthias Pierce3, Tim Millar3, A E Ades1, Nicky J Welton1, Anne M Presanis4, Daniela De Angelis2,4, Matthew Hickman1.   

Abstract

BACKGROUND AND AIMS: Indirect estimation methods are required for estimating the size of populations where only a proportion of individuals are observed directly, such as problem drug users (PDUs). Capture-recapture and multiplier methods are widely used, but have been criticized as subject to bias. We propose a new approach to estimating prevalence of PDU from numbers of fatal drug-related poisonings (fDRPs) using linked databases, addressing the key limitations of simplistic 'mortality multipliers'.
METHODS: Our approach requires linkage of data on a large cohort of known PDUs to mortality registers and summary information concerning additional fDRPs observed outside this cohort. We model fDRP rates among the cohort and assume that rates in unobserved PDUs are equal to rates in the cohort during periods out of treatment. Prevalence is estimated in a Bayesian statistical framework, in which we simultaneously fit regression models to fDRP rates and prevalence, allowing both to vary by demographic factors and the former also by treatment status.
RESULTS: We report a case study analysis, estimating the prevalence of opioid dependence in England in 2008/09, by gender, age group and geographical region. Overall prevalence was estimated as 0.82% (95% credible interval = 0.74-0.94%) of 15-64-year-olds, which is similar to a published estimate based on capture-recapture analysis.
CONCLUSIONS: Our modelling approach estimates prevalence from drug-related mortality data, while addressing the main limitations of simplistic multipliers. This offers an alternative approach for the common situation where available data sources do not meet the strong assumptions required for valid capture-recapture estimation. In a case study analysis, prevalence estimates based on our approach were surprisingly similar to existing capture-recapture estimates but, we argue, are based on a much more objective and justifiable modelling approach.
© 2020 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Keywords:  Bayesian analysis; capture-recapture; hidden populations; indirect estimation; multiplier methods; synthetic estimation

Mesh:

Year:  2020        PMID: 32392631     DOI: 10.1111/add.15111

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  6 in total

1.  What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size.

Authors:  Katherine M Keyes; Caroline Rutherford; Ava Hamilton; Joshua A Barocas; Kitty H Gelberg; Peter P Mueller; Daniel J Feaster; Nabila El-Bassel; Magdalena Cerdá
Journal:  Drug Alcohol Depend Rep       Date:  2022-04-08

2.  Healthcare use by people who use illicit opioids (HUPIO): development of a cohort based on electronic primary care records in England.

Authors:  Dan Lewer; Prianka Padmanathan; Muhammad Qummer Ul Arfeen; Spiros Denaxas; Harriet Forbes; Arturo Gonzalez-Izquierdo; Matt Hickman
Journal:  Wellcome Open Res       Date:  2021-05-05

3.  Using Economic Evaluation to Inform Responses to the Opioid Epidemic in the United States: Challenges and Suggestions for Future Research.

Authors:  Thomas Patton; Paul Revill; Mark Sculpher; Annick Borquez
Journal:  Subst Use Misuse       Date:  2022-02-14       Impact factor: 2.164

4.  Addressing delayed case reporting in infectious disease forecast modeling.

Authors:  Lauren J Beesley; Dave Osthus; Sara Y Del Valle
Journal:  PLoS Comput Biol       Date:  2022-06-03       Impact factor: 4.779

5.  Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia.

Authors:  Antoine Chaillon; Chrianna Bharat; Jack Stone; Nicola Jones; Louisa Degenhardt; Sarah Larney; Michael Farrell; Peter Vickerman; Matthew Hickman; Natasha K Martin; Annick Bórquez
Journal:  Addiction       Date:  2021-12-04       Impact factor: 7.256

6.  Invited Commentary: Drug Checking for Novel Insights Into the Unregulated Drug Supply.

Authors:  Nabarun Dasgupta; Mary C Figgatt
Journal:  Am J Epidemiol       Date:  2022-01-24       Impact factor: 4.897

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.